{"id":134588,"name":"HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA)","slug":"healthcare-distribution-alliance-formerly-hdma","state":"VA","country":"United States of America","description":"","totalSpending":13189757,"filings":32,"yearlySpending":[{"year":2018,"income":1234042},{"year":2019,"income":1258682},{"year":2020,"income":1270147},{"year":2021,"income":1150469},{"year":2022,"income":1624853},{"year":2023,"income":2407035},{"year":2024,"income":2067849},{"year":2025,"income":2176680}],"issues":[{"code":"TAX","display":"Taxation/Internal Revenue Code"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"HCR","display":"Health Issues"},{"code":"PHA","display":"Pharmacy"}],"firms":["HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA)"],"lobbyists":["PATRICK KELLY","ELIZABETH GALLENAGH","KRISTEN FREITAS","JEWELYN COSGROVE","NICOLETTE LOUISSAINT COURSEY","CHESTER DAVIS","KIRSTEN FOSTER","KALA SHANKLE"],"govEntities":["Food & Drug Administration (FDA)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Drug Enforcement Administration (DEA)","White House Office","Centers For Medicare and Medicaid Services (CMS)"],"sampleDescriptions":["LIFO Accounting Methodology (H.R. 1)","Average Sales Price (HR 1920, S 1304); PPACA implementation (PL 111-148); Centers for Medicare and Medicaid Services (AMP and NADAC)","HR 1892 Bipartisan Budget Act; HR 1625 Consolidated Appropriations At of 2018","Pandemic All-Hazards Preparedness Act","Ensuring Patient Access and Effective Enforcement Act (Public Law 114-145); Prescription Drug Abuse - General issues related to Rx drug abuse; Importation of Prescription Drugs (S 469, S 771, HR 1776,"]}